Perioperative gabapentin does not reduce postoperative morphine consumption after THA .
Randomized controlled trial of gabapentin as an adjunct to perioperative analgesia in total hip arthroplasty patients
Can J Anaesth. 2015 May;62(5):476-84102 patients undergoing primary total hip arthroplasty (THA) were randomized to receive either gabapentin or a placebo preoperatively and for two days postoperatively. The purpose of this study was to determine if gabapentin was effective in reducing postoperative morphine consumption and morphine-associated adverse events. Results demonstrated no significant differences between groups in total morphine consumption over the first 72 hours postoperatively. There were also no significant differences noted in pain or the incidence of morphine-related side effects.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
